revivapharma.com (RVPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Reviva Pharmaceuticals - RVPH emitenti grafik logotipi

Antipsixotik dori vositasini tijoratlashtirish uchun global hamkor qidiruvi Reviva Pharmaceuticals (RVPH) kompaniyasining o'sish trayektoriyasini belgilaydi. Uzoq muddatli qarzning kapitalga nisbati ushbu strategiyani tasdiqlaydi, bunda ko'rsatkich 0.00 darajasida turibdi. Reviva Pharmaceuticals (RVPH) ishlab chiqarish va tadqiqotlarni CRO/CMO orqali autsorsing qilishga tayanadi, kelajakdagi daromadlar esa davlat xaridlari va psixiatriya klinikalarining sug'urta to'lovlariga asoslanadi.

Reviva Pharmaceuticals Holdings Inc. (RVPH): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 16.05.2026gacha

Reviva Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Reviva Pharmaceuticals Holdings Inc.|RVPH - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Reviva Pharmaceuticals Holdings, Inc.|RVPH - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Reviva Pharmaceuticals|RVPH - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati revivapharma.com|RVPH - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Reviva Pharmaceuticals|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati revivapharma.com|RVPH - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Reviva Pharmaceuticals Holdings, Inc.|RVPH - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Reviva Pharmaceuticals|Oraliq qoplama koeffitsiyenti revivapharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
RVPH - Sof daromad
Kompaniyaning jamlanma tahlili:RVPH (Reviva Pharmaceuticals Holdings Inc.)
revivapharma.com original mahsuloti

Konservativ aktivlarni tanlash fundamental xatarlarni kamaytirish uchun qarz yuklamasini minimallashtirishni talab qiladi. Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni umumiy kapital bilan solishtirib, moliyaviy leveraj darajasini aniqlaydi. Bioteknologiya sektori va Reviva Pharmaceuticals (RVPH) uchun bu patentlar yaratilishi va terapiya ishlab chiqilishi davrida juda muhimdir. Qarz kapitalining barqarorligi kelajakdagi pul oqimlarining himoyalanishini ta'minlaydi. Uzoq muddatli qarzning kapitalga nisbati dinamikasini tahlil qilish orqali investor kompaniyaning tebranishlarga chidamliligini baholaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|HRMY: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Praxis Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Omeros Corp.|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|NMRA (Neumora) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|CervoMed, Inc. (CRVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Clene (CLNN)|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ANVS|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati Firefly Neuro (AIFF)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|NeuroSense Therapeutics (NRSN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NeurAxis Inc. (NRXS) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADXN|ALZN: Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati KTTA (Pasithea Therapeutics Corp.)|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|ATXI: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati